address1,address2,city,zip,country,phone,fax,website,industry,industryKey,industryDisp,sector,sectorKey,sectorDisp,longBusinessSummary,companyOfficers,auditRisk,boardRisk,compensationRisk,shareHolderRightsRisk,overallRisk,governanceEpochDate,compensationAsOfEpochDate,executiveTeam,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,dividendRate,dividendYield,exDividendDate,payoutRatio,fiveYearAvgDividendYield,beta,trailingPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,tradeable,enterpriseValue,forwardPE,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,earningsQuarterlyGrowth,netIncomeToCommon,trailingEps,lastSplitFactor,lastSplitDate,enterpriseToRevenue,enterpriseToEbitda,52WeekChange,SandP52WeekChange,lastDividendValue,lastDividendDate,quoteType,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,earningsGrowth,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,symbol,language,region,typeDisp,quoteSourceName,triggerable,customPriceAlertConfidence,regularMarketTime,exchange,longName,regularMarketChangePercent,regularMarketPrice,shortName,messageBoardId,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,market,esgPopulated,marketState,corporateActions,hasPrePostMarketData,firstTradeDateMilliseconds,regularMarketChange,regularMarketDayRange,fullExchangeName,averageDailyVolume3Month,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekChangePercent,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,earningsCallTimestampStart,earningsCallTimestampEnd,isEarningsDateEstimate,epsTrailingTwelveMonths,epsCurrentYear,priceEpsCurrentYear,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,sourceInterval,exchangeDataDelayedBy,averageAnalystRating,cryptoTradeable,trailingPegRatio
Zydus Corporate Park,"Scheme No. 63 Survey No. 536, Khoraj (Gandhinagar) Near Vaishnodevi Circle, Sarkhej Gandhinagar Highw",Ahmedabad,382481,India,91 79 4804 0000,91 79 2686 8337,https://zyduslife.com,Drug Manufacturers - Specialty & Generic,drug-manufacturers-specialty-generic,Drug Manufacturers - Specialty & Generic,Healthcare,healthcare,Healthcare,"Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally. It operates through two segments: Pharmaceuticals and Consumer Products. It offers finished dosage human formulations, such as generics; branded generics; specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; consumer wellness products; animal healthcare products; and products in the therapeutic areas of pain management, neurology, metabolic disorder, and liver diseases. The company provides the products under the Everyuth, Nutralite, SugarFree, Complan, Glucon-D, and Nycil brands. In addition, the company offers a pipeline of biological products in the areas of oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology, and infectious illnesses. Further, it engages in the investment, animal health and veterinary, pharmacy retail, and manpower supply and administration activities. The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022. Zydus Lifesciences Limited was founded in 1952 and is headquartered in Ahmedabad, India. Zydus Lifesciences Limited is a subsidiary of Zydus Family Trust.","[{'maxAge': 1, 'name': 'Dr. Sharvil Pankajbhai Patel', 'age': 45, 'title': 'MD & Executive Director', 'yearBorn': 1979, 'fiscalYear': 2024, 'totalPay': 300000000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Ganesh Narayan Nayak', 'age': 69, 'title': 'COO & Executive Director', 'yearBorn': 1955, 'fiscalYear': 2024, 'totalPay': 140000000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Punit  Patel', 'title': 'President & CEO of America', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Nitinkumar Dalsukhray Parekh', 'title': 'Chief Financial Officer', 'fiscalYear': 2024, 'totalPay': 54310000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Arvind  Bothra', 'title': 'Head of Investor Relations', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Dhaval Narendra Soni', 'title': 'Company Secretary & Compliance Officer', 'fiscalYear': 2024, 'totalPay': 2090000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Vikram  Shukla', 'age': 50, 'title': 'President of Parenteral Operations', 'yearBorn': 1974, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Tushar Dhansukh Shroff', 'title': 'President of Finance', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}]",3,3,4,4,2,1748736000,1735603200,[],86400,2,950.05,945.0,944.0,960.35,950.05,945.0,944.0,960.35,11.0,1.16,1753315200,0.066700004,0.83,0.482,21.297285,708119,708119,1475592,1055393,1055393,0.0,0.0,963062726656,795.0,1324.3,4.14372,905.842,951.1755,11.0,0.011578338,INR,False,933787729920,22.691036,0.19472,248987258,1006230016,0.75147,0.14051,1014440000,238.119,4.0194187,1743379200,1774915200,1743379200,-0.01,45255000064,44.94,5:1,1444089600,4.018,13.543,-0.12441826,0.094471335,11.0,1753401600,EQUITY,957.1,1365.0,795.0,983.5484,970.0,2.74194,hold,31,78079000576,77.619,68950999040,32131999744,1.309,1.885,232415002624,12.19,230.951,0.11241999,0.19284001,169035005952,49759748096,67767001088,-0.004,0.18,0.72730005,0.29667,0.29518998,INR,ZYDUSLIFE.NS,en-US,US,Equity,Delayed Quote,True,HIGH,1750413599,NSI,Zydus Lifesciences Limited,0.74206495,957.1,ZYDUS LIFESCIENCES LTD,finmb_865192,Asia/Kolkata,IST,19800000,in_market,False,POSTPOST,[],False,956807100000,7.049988,944.0 - 960.35,NSE,1475592,162.09998,0.20389934,795.0 - 1324.3,-367.20007,-0.2772786,-12.441826,1747738740,1754564340,1754913600,1747737000,1747737000,True,44.94,45.16147,21.192844,51.257996,0.056586023,5.9244995,0.0062286085,15,15,2.7 - Hold,False,
